BAM vs RMD · P/E 31, rev $4.82B vs P/E 29, rev $5.65B
Brookfield Asset Management Ltd. (BAM) versus ResMed Inc (RMD) — a side-by-side from cached financials, not a winner call.
Brookfield Asset Management Ltd. (BAM) is a asset management company listed on US.
ResMed Inc (RMD) is a medical instruments & supplies company listed on US.
Latest reported BAM revenue for 2025-12-31 was $4.82B. Net income was $2.40B. Revenue was up 21.0% from 2024-12-31 to 2025-12-31. BAM currently screens at market cap $78.23B and trailing P/E 31.4.
Latest reported RMD revenue for 2026-06-30 was $5.65B. Net income was $1.52B. Revenue was up 9.9% from 2025-06-30 to 2026-06-30. RMD currently screens at market cap $37.68B and trailing P/E 28.8.
BAM currently screens at market cap $78.23B and trailing P/E 31.4. RMD currently screens at market cap $37.68B and trailing P/E 28.8.
Not investment advice. Open the BAM and RMD stock pages for the full models.
Not investment advice.